Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The University of Oxford and Brazilian Ministry of Health have announced a joint initiative to set up a global health and clinical research unit in Brazil led by Professor Sue Ann Clemens CBE.

Group of people raising their glasses (champagne flutes) in honour of this collaboration.

The unit – the first of its kind that Oxford has developed in the Americas – will work on developing new drugs and vaccines to drive ongoing human health research. It will also focus on training a new generation of clinical researchers by offering Master’s, PhD studentships and courses in infectious diseases, clinical development and vaccinology.

The COVID-19 pandemic has brought the risk of life-threatening infectious diseases into sharp focus, and both the University and their Brazilian counterparts initially aim to drive research to better prepare and respond to health risks by focussing on COVID-19 vaccines and treatments before potentially branching out into other clinical areas.

The unit is also a culmination of a strong relationship the University has built with Brazilian researchers during the pandemic.

Professor Sir Andrew Pollard said: 'Brazilian researchers and the public of Brazil made an extraordinary contribution to the clinical trials of the Oxford-AstraZeneca vaccine, with more than 10,000 volunteers taking part. We are delighted to forge stronger links with the local research teams to improve human health under the leadership of Professor Clemens.'

The UK Government supports the establishment of an Oxford-Brazil collaborative centre for research and training in Brazil, while other prestigious institutions such as the University of Siena’s Institute for Global Health and International Vaccines Institute in South Korea are also partners.

Marcelo Queiroga, the Brazilian Minister of Health, said: 'This collaboration between leading Brazilian researchers and the team at the University of Oxford behind the Oxford-AstraZeneca vaccine is a major step forward in ensuring we are better prepared for future health threats and train the next generation of experts across our nations.'

 Article source: https://www.ox.ac.uk/news/2021-11-01-oxford-work-brazil-establish-clinical-research-hub

Similar stories

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.

Oral paratyphoid vaccine to begin human trials

The University of Oxford in collaboration with the University of Maryland School of Medicine (UMSoM) has begun recruiting for a Phase I/II trial of a new paratyphoid vaccine in human volunteers in Oxford.

Oxford scientist named Australian of the Year in the UK

The Oxford Vaccine Group’s Lead Statistician, Professor Merryn Voysey, received the prestigious Australian of the Year in the UK award at a gala dinner recently.

Angelman syndrome: first patient to receive potential therapy in Oxford

Things that seemed impossible, only a few years ago, are happening today. The first patient in Europe and one of the first in the world was injected with a potential treatment, GTX-102, in a phase I/II clinical trial in Oxford.

New model for infant leukaemia announced

The breakthrough could lead to development of new treatments for infant Acute Lymphoblastic Leukaemia.

Why it's so hard to treat pain in infants

For decades physicians believed that premature babies didn’t experience pain. Here’s what doctors know now – and the innovative solutions being embraced by today's caregivers.